ArticleJournal of the Endocrine Society2026
Targeted proteomics reveal association between maternal biomarkers and child body weight in the first year of life.
Article in Journal of the Endocrine Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Targeted proteomics reveal association between maternal biomarkers and child body weight in the first year of life.Journal of the Endocrine Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Context: The intrauterine environment strongly influences children's health and development. Distinct cardiovascular biomarkers have been linked to birth weight and later weight gain, with correlations observed in maternal and umbilical cord serum. Objective: To describe (1) maternal cardiovascular biomarker patterns during the second and third trimesters and (2) potential associations between these biomarkers and offspring weight at birth and at 1 year of age. Design: Within the LIFE Child Study, serum samples from 86 healthy mothers at 24 and 36 gestational weeks and cord blood at birth were analyzed using the Olink® Target 96 Cardiovascular III panel. Statistical analyses (Wilcoxon test, Spearman correlation, multivariate regression) were performed in R. Setting: Community-based cohort, Leipzig, Germany. Patients or Other Participants: Eighty-six mother-child pairs from the LIFE Child cohort. Mothers had no pregnancy complications, and all newborns had birth weights between 2500 and 4500 g. Main Outcome Measure: Offspring body weight at 1 year of age. Results: Of 92 maternal serum biomarkers, 88 were detectable. Seventy biomarkers increased significantly from 24 to 36 weeks ( Conclusion: In our cohort, maternal PON3 and ITGB2 were independently associated with early postnatal growth, potentially implicating these biomarkers in fetal programming.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.